Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm.
作者信息
Domienik-Karłowicz Justyna, Jaguszewski Miłosz, Kurzyna Marcin
机构信息
Department of Internal Medicine and Cardiology, Medical University of Warsaw,.
First Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland.
出版信息
Cardiol J. 2020;27(4):347-349. doi: 10.5603/CJ.a2020.0067. Epub 2020 May 18.
Abstract
摘要
相似文献
1
Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm.直接口服抗凝剂用于癌症相关静脉血栓栓塞：是时候改变治疗模式了。
Cardiol J. 2020;27(4):347-349. doi: 10.5603/CJ.a2020.0067. Epub 2020 May 18.
2
Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer.直接口服抗凝剂用于门诊癌症患者的血栓预防
N Engl J Med. 2019 Feb 21;380(8):781-783. doi: 10.1056/NEJMe1816060.
3
Evaluation of the efficacy and safety of apixaban and rivaroxaban in cancer patients receiving concomitant active anti-neoplastic therapy at an outpatient cancer setting.评估在门诊癌症环境下同时接受积极抗肿瘤治疗的癌症患者使用阿哌沙班和利伐沙班的疗效和安全性。
J Oncol Pharm Pract. 2020 Oct;26(7):1650-1656. doi: 10.1177/1078155220901777. Epub 2020 Feb 16.
4
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.静脉血栓栓塞症抗凝延长治疗患者换用直接口服抗凝剂后对患者满意度的影响：SWAN 研究。
PLoS One. 2020 Jun 4;15(6):e0234048. doi: 10.1371/journal.pone.0234048. eCollection 2020.
5
The best direct-acting oral anticoagulant for treatment of venous thromboembolism?用于治疗静脉血栓栓塞症的最佳直接口服抗凝剂是什么？
Lancet Haematol. 2019 Jan;6(1):e4-e5. doi: 10.1016/S2352-3026(18)30211-4. Epub 2018 Dec 14.
6
Anticoagulant Therapy for Venous Thromboembolism in Cancer.癌症患者静脉血栓栓塞的抗凝治疗
N Engl J Med. 2020 Apr 23;382(17):1650-1652. doi: 10.1056/NEJMe2004220. Epub 2020 Mar 29.
7
[Toward the use of direct oral anticoagulants as a first line therapy in cancer-associated venous thromboembolism].[关于使用直接口服抗凝剂作为癌症相关静脉血栓栓塞的一线治疗方法]
Rev Med Interne. 2020 Sep;41(9):575-577. doi: 10.1016/j.revmed.2020.06.001. Epub 2020 Jul 25.
8
[Oral apixaban for the treatment of acute venous thromboembolism].口服阿哌沙班治疗急性静脉血栓栓塞症
Rev Clin Esp (Barc). 2014 Apr;214(3):164. doi: 10.1016/j.rce.2013.11.003.
9
[Thromboprophylaxis in patients with cancer].[癌症患者的血栓预防]
Internist (Berl). 2019 Sep;60(9):1004-1006. doi: 10.1007/s00108-019-0647-y.
10
In the pipeline: new oral anticoagulants for the prevention of venous thromboembolism.正在研发中：用于预防静脉血栓栓塞的新型口服抗凝剂。
Orthopedics. 2009 Jan;32(1):35. doi: 10.3928/01477447-20090101-06.
引用本文的文献
1
Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients.癌症相关静脉血栓栓塞的安全有效治疗：聚焦亚洲患者的直接口服抗凝剂
Exp Hematol Oncol. 2022 Oct 27;11(1):79. doi: 10.1186/s40164-022-00331-9.
本文引用的文献
1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.阿哌沙班治疗与癌症相关的静脉血栓栓塞症。
N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29.
2
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会（ESC）与欧洲呼吸学会（ERS）合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
3
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).癌症合并静脉血栓栓塞症患者中口服 Xa 因子抑制剂与低分子肝素的比较：一项随机试验（SELECT-D）的结果。
J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10.
4
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.依度沙班治疗癌症相关静脉血栓栓塞症。
N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
5
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.癌症患者静脉血栓栓塞风险：系统评价和荟萃分析。
PLoS Med. 2012;9(7):e1001275. doi: 10.1371/journal.pmed.1001275. Epub 2012 Jul 31.
6
Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.静脉血栓栓塞和抗凝对癌症及癌症生存率的影响。
J Clin Oncol. 2009 Oct 10;27(29):4902-11. doi: 10.1200/JCO.2009.22.4584. Epub 2009 Sep 8.
7
Incidence of venous thromboembolism and its effect on survival among patients with common cancers.常见癌症患者静脉血栓栓塞的发生率及其对生存的影响。
Arch Intern Med. 2006 Feb 27;166(4):458-64. doi: 10.1001/archinte.166.4.458.
8
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.低分子量肝素与香豆素类药物用于预防癌症患者复发性静脉血栓栓塞的比较
N Engl J Med. 2003 Jul 10;349(2):146-53. doi: 10.1056/NEJMoa025313.
Zotero 插件